This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignees: Aventis Pharma S.a., Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2000-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2000-2010
Title: Jean-Pierre Vigneron: Innovator in Pharmaceutical Compounds
Introduction
Jean-Pierre Vigneron is a notable inventor based in Boissy-sur-Saint-Yon, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for gene therapy. With a total of 3 patents to his name, Vigneron's work has the potential to impact various medical applications.
Latest Patents
Vigneron's latest patents include groundbreaking inventions such as lipid derivatives of aminoglycosides. These transfecting compounds link an aminoglycoside to a lipid via a spacer, making them useful for the in vitro, ex vivo, or in vivo transfection of nucleic acids into various cell types. Another significant patent involves novel amidinium derivatives, which are particularly useful in gene therapy for transferring therapeutic genes into cells. These pharmaceutical compositions contain unique structural elements that enhance their effectiveness.
Career Highlights
Throughout his career, Jean-Pierre Vigneron has worked with prominent organizations such as Aventis Pharma S.A. and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.
Collaborations
Vigneron has collaborated with esteemed colleagues, including Jean-Marie Lehn and Pierre Lehn. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of scientific knowledge.
Conclusion
Jean-Pierre Vigneron's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in gene therapy and related medical fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile